Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

BACKGROUND: The pathophysiology of schizophrenia, a major psychiatric disorder, remains elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor (RXR) families, belonging to the ligand-activated nuclear receptor superfamily, in schizophrenia, was anal...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:EBioMedicine
Auteurs principaux: Wada, Yuina, Maekawa, Motoko, Ohnishi, Tetsuo, Balan, Shabeesh, Matsuoka, Shigeru, Iwamoto, Kazuya, Iwayama, Yoshimi, Ohba, Hisako, Watanabe, Akiko, Hisano, Yasuko, Nozaki, Yayoi, Toyota, Tomoko, Shimogori, Tomomi, Itokawa, Masanari, Kobayashi, Tetsuyuki, Yoshikawa, Takeo
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7728824/
https://ncbi.nlm.nih.gov/pubmed/33279456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.103130
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires